Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.

por Roeland Huijgen, Iris Kindt, Sjoerd B J Verhoeven, Eric J G Sijbrands, Maud N Vissers, John J P Kastelein, Barbara A Hutten
Publicado 2010